Lehang Lin
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 10%
Papers in
-
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 4
- Ubiquitin and proteasome pathways 4
- RNA Research and Splicing 3
- Genomics and Chromatin Dynamics 2
- Single-cell and spatial transcriptomics 1
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- Dong Yin (13 shared papers)De‐Chen Lin (4 shared papers)Bowen Huang (1 shared paper)Jinhai Yan (1 shared paper)Zi Yin (1 shared paper)Yu Zhou (1 shared paper)Tingting Ma (1 shared paper)Yiping Zou (1 shared paper)
- Journals
- Nucleic Acids Research (2 papers)Oncology Reports (1 paper)Cell Death and Disease (1 paper)Theranostics (1 paper)Cancer Gene Therapy (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Lehang Lin
17 papers receiving 849 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 377
- Hepatology 90
- Molecular Biology 627
- Immunology 157
- Oncology 165
Countries citing papers authored by Lehang Lin
This map shows the geographic impact of Lehang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lehang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lehang Lin more than expected).
Fields of papers citing papers by Lehang Lin
This network shows the impact of papers produced by Lehang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lehang Lin. The network helps show where Lehang Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Lehang Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 255 | |
| 2 | 2017 | 148 | |
| 3 | 2020 | 109 | |
| 4 | 2018 | 56 | |
| 5 | 2020 | 50 | |
| 6 | 2019 | 45 | |
| 7 | 2019 | 43 | |
| 8 | 2020 | 33 | |
| 9 | CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling. | 2020 | 21 |
| 10 | 2021 | 20 | |
| 11 | 2015 | 19 | |
| 12 | 2021 | 17 | |
| 13 | 2013 | 15 | |
| 14 | 2020 | 15 | |
| 15 | 2021 | 7 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 |
About Lehang Lin
Lehang Lin is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Cell Biology, having authored 18 papers that have together received 855 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (4 papers), Ubiquitin and proteasome pathways (4 papers), RNA Research and Splicing (3 papers), Genomics and Chromatin Dynamics (2 papers), Ferroptosis and cancer prognosis (2 papers), Cancer Genomics and Diagnostics (2 papers) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Cancer Research (377 citations), Hepatology (90 citations), Molecular Biology (627 citations), Immunology (157 citations) and Oncology (165 citations). Lehang Lin has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Dong Yin, De‐Chen Lin, Bowen Huang, Jinhai Yan, Zi Yin, Yu Zhou, Tingting Ma, Yiping Zou, Sheng Chen and H. Phillip Koeffler. Their work appears in journals such as Nucleic Acids Research, Oncology Reports, Cell Death and Disease, Theranostics and Cancer Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.